Overview

DDDI Section 

 

Join today! 

The Drug Discovery and Development Interface (DDDI) section focuses on issues at the critical interface between drug discovery and drug development and provides a collaborative forum for interactions among scientists from academia, industry (large and small pharma), and government institutions. DDDI welcomes participation of all AAPS members (as well as colleagues from other professional organizations) whose efforts are directed toward discovering, optimizing, and effectively transitioning preclinical candidates into the clinical development phase.

Find us on

linkedin_logo_35px_2